載入...
Cardiotoxicity with adjuvant trastuzumab use in breast cancer: A single institution’s experience
BACKGROUND: Trastuzumab use in Her-2-neu positive breast cancer patients is the current standard of care. Trastuzumab is known to result in cardiotoxicity. The toxicity seems to be dose-dependent, and serial cardiology assessment with echocardiography is advised. In spite of this, patients do develo...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3727509/ https://ncbi.nlm.nih.gov/pubmed/23960606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsha.2010.04.009 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|